Journal of Nanobiotechnology (Sep 2022)

Vasorin-containing small extracellular vesicles retard intervertebral disc degeneration utilizing an injectable thermoresponsive delivery system

  • Zhiwei Liao,
  • Wencan Ke,
  • Hui Liu,
  • Bide Tong,
  • Kun Wang,
  • Xiaobo Feng,
  • Wenbin Hua,
  • Bingjin Wang,
  • Yu Song,
  • Rongjin Luo,
  • Huaizhen Liang,
  • Weifeng Zhang,
  • Kangcheng Zhao,
  • Shuai Li,
  • Cao Yang

DOI
https://doi.org/10.1186/s12951-022-01624-1
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Intervertebral disc degeneration (IDD) is the pathological reason of back pain and the therapeutic approaches are still unsatisfactory. Recently, mesenchymal stem cell-derived small extracellular vesicles (EVs) have emerged as the novel regenerative method for IDD. In this study, we intensively investigated the therapeutic mechanism of small EVs, and found that vasorin protein enriched in EVs promoted the proliferation and extracellular matrix anabolism of nucleus pulposus cells via the Notch1 signaling pathway. Then, we fabricated a thermoresponsive gel which composed of Pluronic F127 and decellularized extracellular matrix (FEC) for the delivery and sustained release of EVs. Besides, ex vivo and in vivo results showed that EVs embedded in FEC (EVs@FEC) ameliorate the disc degeneration efficiently and achieve better therapeutic effects than one-off EVs delivery. Collectively, these findings deepen the understanding of EVs mechanism in treating intervertebral disc degeneration, and also illustrate the promising capacity of sustained EVs release system for intervertebral disc regeneration.

Keywords